DBV Technologies | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amarin USD -16755000 35.77M 2025-03
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
DBV Technologies USD -26618000 2.76M 2025-03
Halozyme Therapeutics USD 202.44M 60.91M 2025-06
Incyte USD 310.82M 105.66M 2025-06
Insmed USD -253876000 5.74M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
PTC Therapeutics USD -34858000 1.01B 2025-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
United Therapeutics USD 276.9M 105.9M 2025-06


DBV Technologies Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.